Urocortin-2 induces vasorelaxation of coronary arteries isolated from patients with heart failure.

Smani, Tarik; Calderon, Eva; Rodriguez-Moyano, Maria; Dominguez-Rodriguez, Alejandro; Diaz, Ignacio; Ordóñez, Antonio

Smani, Tarik; Calderon, Eva; Rodriguez-Moyano, Maria; Dominguez-Rodriguez, Alejandro; Diaz, Ignacio; Ordóñez, Antonio.

Affiliation

Smani T; Institute of Biomedicine from Seville, Universitary Hospital of Virgen del Rocío, University of Seville, Spain. tasmani@us.es

Clin Exp Pharmacol Physiol ; 38(1): 71-6, 2011 Jan.

Article in En | MEDLINE | ID: mdl-21105894

Subject(s)

Coronary Vessels/drug effects; Coronary Vessels/physiopathology; Heart Failure/pathology; Urocortins/pharmacology; Vasodilation/drug effects; Adenylyl Cyclases/metabolism; Adenylyl Cyclases/physiology; Adult; Coronary Vessels/pathology; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enzyme Activation/drug effects; Enzyme Activation/physiology; Humans; In Vitro Techniques; Isotonic Contraction/drug effects; Isotonic Contraction/physiology; Middle Aged; Tensile Strength/drug effects; Tissue and Organ Harvesting; Vasodilation/physiology; Vasodilator Agents/pharmacology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Vasodilation / Coronary Vessels / Urocortins / Heart Failure Limits: Adult / Humans / Middle aged Language: En Year: 2011 Type: Article

Fulltext

XML

PubMed Links

Search on Google